Rhythm Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Rhythm Pharmaceuticals patents 11 in total

Status Patent
Application
Utility: METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS External link
Filling date: 6 Sep 2025 Issue date: 26 May 2022
Application
Utility: METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: COMPOSITIONS FOR TREATING KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: SUSTAINED RELEASE PEPTIDE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Grant
Utility: Method of treating melanocortin-4 receptor pathway-associated disorders External link
Filling date: 6 Sep 2025 Issue date: 30 Mar 2021
Grant
Utility: Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers External link
Filling date: 6 Sep 2025 Issue date: 23 Mar 2021
Application
Utility: METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS External link
Filling date: 6 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: PEPTIDE COMPOSITIONS External link
Filling date: 6 Sep 2025 Issue date: 11 Feb 2021
Grant
Utility: Peptide compositions External link
Filling date: 6 Sep 2025 Issue date: 8 Dec 2020
Application
Utility: METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS External link
Filling date: 6 Sep 2025 Issue date: 16 Jan 2020

Showing 1 to 11 of 11 patents.